TABLE 1.
Sample characteristics | |||||
---|---|---|---|---|---|
Low mood | N | % | Typical mood | N | % |
Biological sex | Biological sex | ||||
Female | 39 | 67.2 | Female | 41 | 70.7 |
Male | 19 | 32.8 | Male | 17 | 29.3 |
Race | Race | ||||
American Indian or Alaska Native | 0 | 0.0 | American Indian or Alaska Native | 0 | 0.0 |
Asian | 4 | 6.9 | Asian | 4 | 6.9 |
Black or African American | 6 | 10.3 | Black or African American | 7 | 12.1 |
Native Hawaiian or other Pacific Islander | 0 | 0.0 | Native Hawaiian or other Pacific Islander | 1 | 1.7 |
White | 41 | 70.7 | White | 41 | 70.7 |
Other | 1 | 1.7 | Other | 0 | 0.0 |
More than one race | 6 | 10.3 | More than one race | 5 | 8.6 |
Ethnicity | Ethnicity | ||||
Hispanic or Latino | 5 | 8.6 | Hispanic or Latino | 4 | 6.9 |
Not Hispanic or Latino | 53 | 91.4 | Not Hispanic or Latino | 54 | 93.1 |
Current diagnoses (DSM‐5) | Current diagnoses (DSM‐5) | ||||
Major depressive episode | 25 | 43.1 | Major depressive episode | 0 | 0.0 |
Generalized anxiety disorder | 10 | 17.2 | Generalized anxiety disorder | 0 | 0.0 |
Social anxiety disorder | 7 | 12.1 | Social anxiety disorder | 0 | 0.0 |
Panic disorder | 2 | 3.5 | Panic disorder | 0 | 0.0 |
Specific phobia | 1 | 1.7 | Specific phobia | 0 | 0.0 |
Attention‐deficit/ | Attention‐deficit/ | ||||
Hyperactivity disorder | 4 | 6.9 | Hyperactivity disorder | 0 | 0.0 |
Oppositional defiant disorder | 2 | 3.5 | Oppositional defiant disorder | 0 | 0.0 |
Medication | Medication | ||||
SSRI | 9 | 15.5 | SSRI | 0 | 0.0 |
M | SD | M | SD | ||
Age (in years) | 15.9 | 1.8 | Age (in years) | 16.1 | 1.9 |
Family income (dollars) | 126,000 | 68,000 | Family income (dollars) | 179,000 | 147,000 |
SHAPS score | 34.4 | 5.8 | SHAPS score | 18.5 | 4.5 |
CES‐D score | 33.4 | 9.9 | CES‐D score | 5.8 | 5.0 |
Note: There were no group differences in sex, race, ethnicity, or age (ps > .65). There were group differences in SHAPS (p < .001) and CESD severity (p < .001), as well as income (p = .025; 16 subjects did not report their income).
Abbreviations: DSM‐5, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition; SHAPS, Snaith‐Hamilton Pleasure Scale; SSRI, selective serotonin reuptake inhibitor.